Drug Cuts Amputation Risk in Diabetes
Study: Cholesterol Drug Fenofibrate Also Decreases Diabetes-Related Amputation Treating type 2 diabetes patients with a cholesterol-lowering drug called fenofibrate cuts the risk of a first diabetes-related limb amputation by 36%, according to a new study published this week in The Lancet. “I would call that a substantial reduction in risk,”... more
